- Datacubed Health, headquartered in King of Prussia, Pennsylvania, specializes in digital health technology that enhances hybrid and decentralized clinical trials through advanced ePRO/eCOA solutions and patient engagement tools.
- In December 2022, Datacubed announced a remarkable 150% year-over-year revenue growth since 2018, supported by a total of $45 million in funding from Sterling Partners, which has been a key investor since 2020.
- The company has recently partnered with ATCOR Medical to expand its product offerings, enhancing its capabilities in connected sensors and integrations for clinical trials.
- Datacubed's ideal buyers are clinical research organizations and pharmaceutical companies seeking to improve patient engagement and streamline clinical trial processes, making it a timely opportunity for sales teams to engage with these sectors.
Datacubed Health operates with a diverse departmental structure comprising nine distinct areas. The largest department is Information Technology, which employs nine individuals, followed closely by Operations with eight. Sales and Engineering contribute five and three employees, respectively, indicating a strong focus on both technical and operational capabilities. The balance across departments suggests a well-rounded approach to software development and service delivery.
The company's workforce is distributed across 16 locations, with the highest concentration in Brooklyn, NY, housing nine employees. Philadelphia, PA follows with four employees, while Winston Salem, NC contributes two. The presence of 20 employees categorized under 'Other' indicates a significant remote or distributed workforce, reflecting the company's flexibility in location strategy and a broad geographic reach.
